REAL

Effects of aging on cardiac extracellular matrix in men and women

Dworatzek, E. and Baczkó, István and Kararigas, G. (2016) Effects of aging on cardiac extracellular matrix in men and women. PROTEOMICS CLINICAL APPLICATIONS, 10 (1). pp. 84-91. ISSN 1862-8346

[img] Text
DworatzekBaczkoProteomicsClinAppl2016.pdf
Restricted to Registered users only

Download (807kB) | Request a copy

Abstract

PURPOSE: Aging has severe implications for tissue damage and is a major risk factor for disease. However, the effects of aging on cardiac extracellular matrix (ECM) components in individuals free of cardiovascular disease are incompletely understood. We aimed at the characterization of the effects of aging on major ECM proteins in the heart of men and women. EXPERIMENTAL DESIGN: Left ventricular (LV) samples of nondiseased human hearts technically unusable for transplantation obtained from general organ donors (n = 31; age 17-68 years; 48% women) were used for protein isolation. We separated the group into 17-40 years (n = 7 men and 7 women) and 50-68 years (n = 9 men and 8 women). RESULTS: Analysis of ECM proteins demonstrated an age-dependent sex-specific regulation of collagen type I and III (interaction p < 0.05), type VI (interaction p = 0.01), tissue inhibitor of metalloproteinase 3 (interaction p < 0.05), SMAD2 (interaction p < 0.05), and SMAD3 (interaction p = 0.001). Overall, the levels of these proteins in younger individuals were lower in women than men, while in older individuals they were higher in women than men. CONCLUSIONS AND CLINICAL RELEVANCE: This age-mediated myocardial ECM remodeling might play a key role in the limited ability of the aging heart to adapt adequately to altered work load and to respond to tissue damage. Therapeutic agents that target ECM homeostasis represent promising prevention strategies.

Item Type: Article
Additional Information: Cited By :16 Export Date: 17 September 2019 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins Cited By :16 Export Date: 31 October 2019 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins Cited By :16 Export Date: 4 November 2019 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins Cited By :17 Export Date: 10 December 2019 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins Cited By :19 Export Date: 23 January 2020 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins Cited By :25 Export Date: 9 July 2020 Correspondence Address: Kararigas, G.; Institute of Gender in Medicine and Center for Cardiovascular Research, Charite University Hospital, Hessische Str. 3-4, Germany; email: george.kararigas@charite.de Chemicals/CAS: gelatinase A, 146480-35-5; gelatinase B, 146480-36-6; Smad2 protein, 253862-89-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; tissue inhibitor of metalloproteinase 2, 124861-55-8; tissue inhibitor of metalloproteinase 3, 145809-21-8, 164781-40-2; Extracellular Matrix Proteins
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 07 Jan 2021 17:15
Last Modified: 07 Jan 2021 17:21
URI: http://real.mtak.hu/id/eprint/119292

Actions (login required)

Edit Item Edit Item